Latest

2 stories

Hide weekly roundups

Thursday, August 6

Quarterly updateAmphastar Pharmaceuticals, Inc.Eli Lilly glucagon

Amphastar hits BAQSIMI sales milestone, triggering $100 million payment to Lilly

The Q2 2026 filing discloses a $100 million payment due to Eli Lilly in Q3 2026 after BAQSIMI sales crossed a contract threshold, alongside new pipeline detail and an April ipratropium bromide launch.

SEC filing

Monday, July 13

PeopleAmphastar Pharmaceuticals, Inc.

Amphastar expands board, adds Anthony Pierce as director

Amphastar Pharmaceuticals' board grew to eleven seats on July 9, 2026, with Anthony Pierce joining as a Class III director through 2028.

SEC filing